A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain.
You are invited to participate in the Novavax_2019nCoV-205study. This app is specifically...
Today’s rapidly changing healthcare landscape presents new challenges and disruptions to patient...
This app is specifically intended for study participants in the ZEUS (EX6018-4758)...
A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions...
You are invited to participate in the Option VMS study....
Welcome to your Pegasus FLY patient application. This application is designed for...
Created with AppPage.net
Similar Apps - visible in preview.